Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-c...

por Nauck, Michael A., Del Prato, Stefano, Meier, Juris J., Durán-García, Santiago, Rohwedder, Katja, Elze, Martina, Parikh, Shamik J.
Publicado 2011

Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

por Aberle, Jens, Menzen, Markus, Schmid, Sebastian M., Terkamp, Christoph, Jaeckel, Elmar, Rohwedder, Katja, Scheerer, Markus F., Xu, John, Tang, Weifeng, Birkenfeld, Andreas L.
Publicado 2020

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes

por Müller‐Wieland, Dirk, Kellerer, Monika, Cypryk, Katarzyna, Skripova, Dasa, Rohwedder, Katja, Johnsson, Eva, Garcia‐Sanchez, Ricardo, Kurlyandskaya, Raisa, Sjöström, C. David, Jacob, Stephan, Seufert, Jochen, Dronamraju, Nalina, Csomós, Katalin
Publicado 2018